# Bundibugyo virus

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/bundibugyo-virus-company
Canonical HTML page: https://getbiobrief.com/entity/bundibugyo-virus-company

## Timeline

- **2026-07-25**: Elikya Treatment Center strike — About 100 health workers at the Elikya Ebola Treatment Center in Bunia strike over unpaid bonuses, paralyzing patient care.
- **2026-07-24**: Government releases updated data — Congo's Ministry of Health confirms 2,973 cases and 1,309 deaths, the fastest-growing outbreak on record.
- **2026-07-18**: Strike at Bunia General Hospital — Health workers at the region's largest hospital strike over unpaid salaries, stating they have not been paid since the outbreak started.
- **2026-07-10**: Record outbreak data confirmed — Africa CDC reports the outbreak as the fastest-growing ever at 1,830 confirmed cases and 648 deaths. U.S. aid worker infection announced by CDC.
- **2026-07-06**: Clinical trials for treatments launched — Researchers initiate a highly anticipated clinical study to test experimental therapies against the Bundibugyo virus.
- **2026-07**: Kenya court suspends U.S.-backed facility — A Kenyan court order halts construction of a U.S.-planned quarantine facility for Americans exposed abroad, complicating evacuation plans.
- **2026-05-15**: Ebola outbreak officially declared — Congolese authorities declare a fresh Ebola outbreak after weeks of undetected transmission, as later confirmed by WHO.
- **2026-05-15**: Outbreak officially begins — The first cases of Ebola caused by the Bundibugyo virus are reported in eastern Congo.
- **2026-05**: First U.S. doctor infected and evacuated — An American doctor working in Congo tests positive for Ebola and is transferred to Germany for treatment during the outbreak’s first week.

## Recent coverage (2 stories)

### Bundibugyo Ebola Hits 2,973 Cases, 1,309 Deaths: A Biotech Call to Arms
2026-07-25 13:34:07 · Sentiment: Very Bearish · Impact: 8/10 · Sources: 2

The Bundibugyo virus outbreak is the fastest-growing on record, with a 44% case fatality rate and no approved vaccine or therapy. Biopharma companies and researchers face a critical test as containment fails and the need for medical countermeasures becomes more urgent.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-2973-biotech

### Bundibugyo Ebola Outbreak at 1,830 Cases Spurs Urgent Clinical Trials
2026-07-23 23:43:52 · Sentiment: Very Bearish · Impact: 8/10 · Sources: 2

With no approved vaccine or treatment, the rare Bundibugyo ebolavirus driving the Congo outbreak has infected 1,830 people and killed 648. As two U.S. workers fall ill, recently launched clinical trials represent the only hope for a therapeutic breakthrough.
Full story: https://getbiobrief.com/story/bundibugyo-ebola-outbreak-clinical-trials-begin

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.